Related Experiment Video
Updated: May 5, 2026

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
Published on: December 27, 2013
Engineered Polylactic Acid (PLA) Microcapsules for Spatiotemporally Coupled Delivery and Synergistically Enhanced
Shaoyu Guan1, Yu Zhang2,3, Hongyi Liu2,3
1Pharmaceutical Sciences Research Division, Department of Pharmacy, Medical Supplies Centre of PLA General Hospital, Medical School of Chinese PLA, Beijing 100853, China.
This study developed advanced microcapsule vaccines that enhance immune responses. The polylactic acid (PLA) microcapsules with monophosphoryl lipid A (MPLA) show potent therapeutic and anti-infectious vaccine potential.
Area of Science:
- Vaccinology
- Materials Science
- Immunology
Background:
- Microcapsules are researched as particulate adjuvants in vaccine development.
- Designing effective microcapsule-based composite adjuvant systems remains challenging.
Purpose of the Study:
- To develop polylactic acid (PLA) microcapsules with combined delivery and immunopotentiator properties.
- To evaluate the humoral and cellular immune responses elicited by these microcapsule formulations in mice.
Main Methods:
- Preparation of uniform polylactic acid (PLA) microcapsules (MC) and monophosphoryl lipid A (MPLA) composite microcapsules (MPLA@MC).
- Formulation of ovalbumin (OVA) loaded microcapsules (OVA@MC) and composite microcapsules (OVA&MPLA@MC).
- Assessment of cellular uptake, lysosomal escape, in vivo humoral and cellular immune responses, and immune pathway activation via RNA sequencing.
Main Results:
- Microcapsule formulations promoted cellular uptake and lysosomal escape.
- OVA&MPLA@MC significantly enhanced IgG antibody levels and induced Th1-biased responses.
- Strong cellular immunity was observed, with increased Interferon-γ (IFN-γ) and Granzyme B (Gzmb) secretion, enhanced phagocytosis, and activated immune signaling pathways.
Conclusions:
- A rationally designed composite microcapsule strategy offers a potent platform for synergistic immune responses.
- This approach opens new avenues for developing effective therapeutic and anti-infectious vaccines.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted

